A mind-altering medication related to the recreational drug ketamine won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness.
Depression has long been linked to certain cognitive problems, and depression late in life even may be a risk factor for the development of Alzheimer's. Yet how depression might harm cognition isn't clear.
The Flemish Gut Flora Project examined depression data and stool samples from more than 1,000 people and found that two types of bacteria were "consistently depleted" in those who suffered from depression.
Almost half of teen girls in Ontario are suffering from moderate to serious anxiety or depression, with many choosing to seek medical care, and others revealing they rarely talk to their parents about their problems.
A new therapy-based program that emphasizes parent-child interaction and emotional development shows promise for treating early childhood depression, according to research published Wednesday in the American Journal of Psychiatry.
A trial is underway for a cutting-edge procedure that uses ultrasound beams directed into the brain to alter a pathway known to be at least in part responsible for such psychiatric conditions as depression, obsessive-compulsive disorder and post-traumatic stress disorder.